AFINITOR vs NINTEDANIB

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 23, 2026·How we rate

Possible drug interaction. AFINITOR and NINTEDANIB are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	AFINITOR	NINTEDANIB
Rating	70/100	New
Pharmacy pays	~$229.16 /30	—
Type	RX	RX
Active ingredient	EVEROLIMUS	NINTEDANIB
Manufacturer	Novartis	Teva Pharmaceuticals Development Inc
Dosage forms	Tablet	Capsule
Drug class	Kinase Inhibitor	Kinase Inhibitor
Boxed warning	None	None
Half-life	about 30 hours (mean terminal elimination half-life)	—
Treats	—	Idiopathic Pulmonary Fibrosis

afinitor nintedanib

Rating

70/100

New

Pharmacy pays

~$229.16 /30

—

Type

Active ingredient

EVEROLIMUS

NINTEDANIB

Manufacturer

Novartis

Teva Pharmaceuticals Development Inc

Dosage forms

Tablet

Capsule

Drug class

Kinase Inhibitor

Boxed warning

None

Half-life

about 30 hours (mean terminal elimination half-life)

—

Treats

—

Idiopathic Pulmonary Fibrosis

Frequently asked questions

What is the difference between Afinitor and Nintedanib?

Afinitor contains Everolimus, while Nintedanib contains Nintedanib — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.